Testimony
Read the NWHN’s testimony to the FDA in support of OPILL, an oral contraceptive, being approved for over-the-counter dispensation.
Read the NWHN’s written testimony in support of the WHPA.
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
Comments submitted to the Vaccines and Related Biological Products Advisory Committee
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
Oral Presentation Delivered to the Center for Devices and Radiological Health Virtual Public Meeting
Testimony Delivered to the Vaccines and Related Biological Products Advisory Committee
Public comments urging the FDA’s Office of Women’s Health to ensure that women’s needs are represented across FDA and in the agency’s research, education, and public outreach.
Statement from M. Isabelle Chaudry, Esq., Senior Policy Manager, National Women’s Health Network: House Ways and Means Committee
U.S. Food & Drug Administration Public Meeting on Testing Methods for Asbestos in Talc and Cosmetic Products Containing Talc